Newborn screening (NBS) programmes for cystic fibrosis (CF) have been successfully implemented in many European countries and the number of countries planning such programs is still increasing. There is agreement that NBS for CF offers the opportunity for early intervention and improved outcomes. It is however important to take precautions in order to minimize avoidable risk and maximise benefits. The aim of this web-based course is to update the participants on the management of infants identified with cystic fibrosis following newborn screening by addressing the following topics: Importance of a multidisciplinary team and care; confirmation of diagnosis  after screening including sweat testing; the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis; early respiratory assessment and clinical management in symptomatic and asymptomatic children; early nutritional management; the measures to take in order to prevent cross-infection and psychosocial aspects and family management.
 

Oct 19 - Nov 30, 2010
Weekly lectures of 60 min
 
Registration fee: € 50